Xeris Biopharma Holdings, Inc. (XERS)
8.74
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 16:00
8.75
+0.01
(+0.11%)
After-Hours: 19:59
Xeris Biopharma Holdings Price : 8.74 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 8.81 | 8.95 | 8.665 | 8.74 | 1.006M |
| Aug 24, 2026 | 8.66 | 8.80 | 8.539 | 8.74 | 870743.0 |
| Aug 21, 2026 | 8.61 | 8.81 | 8.535 | 8.70 | 1.563M |
| Aug 20, 2026 | 8.91 | 8.985 | 8.56 | 8.60 | 2.001M |
| Aug 19, 2026 | 8.93 | 9.02 | 8.77 | 8.78 | 2.250M |
| Aug 18, 2026 | 8.58 | 8.88 | 8.47 | 8.85 | 2.142M |
| Aug 17, 2026 | 8.45 | 8.545 | 8.259 | 8.52 | 1.335M |
| Aug 14, 2026 | 8.33 | 8.67 | 8.25 | 8.60 | 1.366M |
| Aug 13, 2026 | 8.59 | 8.70 | 8.30 | 8.33 | 1.852M |
| Aug 12, 2026 | 8.365 | 8.52 | 8.235 | 8.49 | 1.729M |
| Aug 11, 2026 | 8.00 | 8.436 | 7.96 | 8.39 | 1.779M |
| Aug 10, 2026 | 7.96 | 8.07 | 7.80 | 7.99 | 1.616M |
| Aug 07, 2026 | 7.43 | 8.02 | 7.43 | 7.93 | 2.253M |
| Aug 06, 2026 | 7.19 | 7.435 | 7.05 | 7.36 | 3.725M |
| Aug 05, 2026 | 8.21 | 8.37 | 8.055 | 8.11 | 1.751M |
| Aug 04, 2026 | 8.13 | 8.28 | 8.04 | 8.19 | 1.844M |
| Aug 03, 2026 | 8.135 | 8.171 | 7.865 | 8.13 | 1.947M |
| Jul 31, 2026 | 8.34 | 8.405 | 7.99 | 8.08 | 1.624M |
| Jul 30, 2026 | 8.38 | 8.455 | 8.32 | 8.42 | 920973.0 |
| Jul 29, 2026 | 8.23 | 8.485 | 8.23 | 8.38 | 1.195M |
| Jul 28, 2026 | 8.28 | 8.33 | 8.125 | 8.24 | 811644.0 |
| Jul 27, 2026 | 8.40 | 8.465 | 8.20 | 8.21 | 873434.0 |
| Jul 24, 2026 | 8.42 | 8.54 | 8.29 | 8.32 | 1.176M |
| Jul 23, 2026 | 8.29 | 8.435 | 8.142 | 8.41 | 2.191M |
| Jul 22, 2026 | 8.75 | 8.76 | 8.29 | 8.38 | 2.261M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Zevra Therapeutics, Inc. | 12.04 |
| Aclaris Therapeutics, Inc. | 6.535 |
| ANI Pharmaceuticals, Inc. | 75.65 |
| Corcept Therapeutics, Inc. | 123.57 |
| Veru, Inc. | 2.71 |
Price Related Metrics
| PS Ratio | 4.613 |
| Price to Free Cash Flow | 27.79 |
| Earnings Yield | -1.17% |
| Market Cap | 1.517B |
| Operating PE Ratio | 42.28 |
| Normalized PE Ratio | 391.93 |